Evercore ISI Group maintains Hinge Health at Outperform, raises price target to $150 from $125

What happened

Evercore ISI Group kept its Outperform rating on Hinge Health and raised its price target to $150 from $125, a 20.0% increase. The new target implies 29.9% upside from the Nov 2 close of $115.48.

Confirmed

Global impact / market context

A higher price target signals that this analyst expects more room for the stock to rise, which can draw buyer interest. For a beginner, a price target is an analyst's estimate of where a stock could go, not a guarantee.

Analyst inference

The five most recent analyst notes on Hinge Health show price targets between $110 and $140, so Evercore's $150 sits above that recent range. That gap suggests a more optimistic view than peers on the company's path.

Analyst inference

What to watch

1. The article lists five recent analyst notes with price targets from $110 to $140, showing the spread of views on Hinge Health. Confirmed
2. Watch whether other analysts raise their own price targets toward $150, which would show a wider shift in expectations. Proposed
3. Watch the share price relative to the $150 target and $115.48 close, since a narrowing gap would mean less implied upside remains. Analyst inference

Evidence

• Original source link unavailable